Asensus Surgical, Inc. (ASXC)
| Market Cap | 84.29M |
| Revenue (ttm) | 5.61M |
| Net Income (ttm) | -79.09M |
| Shares Out | 264.32M |
| EPS (ttm) | -0.33 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,842,213 |
| Open | 0.340 |
| Previous Close | 0.339 |
| Day's Range | 0.311 - 0.342 |
| 52-Week Range | 0.200 - 1.180 |
| Beta | 1.52 |
| Analysts | Buy |
| Price Target | 2.00 (+527.16%) |
| Earnings Date | Nov 14, 2023 |
About ASXC
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surge... [Read more]
Financial Performance
In 2022, ASXC's revenue was $7.09 million, a decrease of -13.91% compared to the previous year's $8.23 million. Losses were -$75.56 million, 21.0% more than in 2021.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ASXC stock is "Buy." The 12-month stock price forecast is $2.0, which is an increase of 527.16% from the latest price.
News
Asensus Announces Sale of Senhance Robotic System in Romania
Senhance® System to be placed at a pediatric hospital in Timisoara, Romania Senhance® System to be placed at a pediatric hospital in Timisoara, Romania
Senhance Robotic System Sold by Asensus Surgical
Senhance® System to be placed at a hospital in the Commonwealth of Independent States Senhance® System to be placed at a hospital in the Commonwealth of Independent States
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023
RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical Announces Sale of Senhance Robotic System
Senhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States Senhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States
Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program
RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical Announces Collaboration with NVIDIA to Enhance Augmented Intelligence Capabilities of the ISU
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical to Participate in the H.C. Wainwright 25th Annual Global Investment Conference and 2023 Cantor Global Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Offic...
Asensus Surgical Announces First Towakai Hospital in Japan to Initiate Senhance Surgery Program
RESEARCH TRIANGLE PARK, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 10, 2023
RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical Announces $10 Million Registered Direct Offering
RESEARCH TRIANGLE PARK, N.C., July 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus” or the “Company”), a medical device company that is digitizing the interface bet...
Asensus Surgical Announces Leading United States-Based Hospital to Initiate Senhance Surgery Program
Senhance® Surgical System to be Exclusively Utilized within the Pediatric Surgery Department Senhance® Surgical System to be Exclusively Utilized within the Pediatric Surgery Department
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2023
RESEARCH TRIANGLE PARK, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pa...
Asensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
System to be Utilized by the Second Largest Private Hospital System in Japan System to be Utilized by the Second Largest Private Hospital System in Japan
Asensus Surgical to Participate in the H.C. Wainwright In-Person BioConnect Investor Conference
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze ...
Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System
Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric Patients Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric Patients
Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze ...
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2022
RESEARCH TRIANGLE PARK, N.C., March 02, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...
Asensus Surgical, Inc. to Release Fourth Quarter and Full Year 2022 Financial and Operating Results on March 2, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical Provides Corporate Update
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms
The Companies intend to collaborate on developing next-generation instrumentation and KARL STORZ intends to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device The Companies intend to...
Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical to Ring New York Stock Exchange Opening Bell on February 21, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...
Asensus Surgical to Host Investor Day on February 21, 2023
RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...